Orexigen Therapeutics to Host Conference Call at 8:30 a.m. Eastern Time Today to Discuss Acquisition of U.S. Rights to Contra... Print Alert Orexigen Therapeutics, Inc. (MM) (NASDAQ:OREX) Intraday Stock Chart Today : Tuesday 15 March 2016
Click Here for more Orexigen Therapeutics, Inc. (MM) Charts. SAN DIEGO, March 15, 2016 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) will host a conference call this afternoon to discuss the strategic acquisition of all U.S. rights to Contrave® and the Mysimba® commercialization and distribution agreement with Valeant Pharmaceuticals International, Inc. for Central and Eastern Europe.
The call will be held today at 8:30 a.m. ET / 5:30 a.m. PT and may be accessed by phone by calling (888) 771-4371 (domestic) or (847) 585-4405 (international), participant code 42093506. The webcast can be accessed live on the Investors section of the Orexigen web site at http://www.orexigen.com, and will be archived for 14 days following the call.
Orexigen Contact:
Media Contact:
McDavid Stilwell
Julie Normart
VP, Corporate Communications and Business Development
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.